Oxidative stress parameters in erythrocytes of post-reperfused patients with myocardial infarction

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 4, 2005, Pages 377-381

  Bhakuni, Pushpa ^a   Chandra, M ^b   Misra, M K ^a  

^a UNIVERSITY OF LUCKNOW   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Antioxidants; Ascorbic acid; Lipid peroxidation; Myocardial infarction; Oxidative stress; RBC's

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATALASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; CATALASE; ERYTHROCYTES; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 24644433017     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360500112409     Document Type: Article

References (39)

1. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992;20:118-127.
2. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264-3265.
3. Dhalla NS, Wang X, Beamish RE. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol 1996;1:7-20.
4. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A. Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 1998;19:B2-11.
5. McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985;312:159-163.
6. Chambers DE, Parks DA, Patterson G, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-152.
7. Schaffer SW, Roy RS, McCord JM. Possible role for calmodulin in calcium paradox-induced heart failure. Eur Heart J 1983;4:H81-H87.
8. Gilham B, Papachristodoulou DK, Thomas JH. Will's biochemical basis of medicine. 3rd ed. Butterworth-Heinemann; 1997. p 343-354.
9. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-416.
10. Plotnick GD, Caretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelial-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 1997;278:1682-1686.
11. Traber MG, Packer L, Vitamin E. Beyond antioxidant function. Am J Clin Nutr 1995;62:1501S-1509S.
12. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S-1118S.
13. Barton Duell P. Prevention of atherosclerosis with dietary antioxidants: Fact or Fiction? J Nutr 1996;106:1067S-1071S.
14. Chen LY, Nichols WW, Hendricks J, Mehta JL. Myocardial neutrophil infiltration, lipid peroxidation and antioxidant activity after coronary artery thrombosis and thombolysis. Am Heart J 1995;129:211-218.
15. Waller BF, Rothbaum DA, Pinkerton CA, Linnemeier TJ, Orr C, et al. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacological (Streptokinase, γ-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J Am Coll Cardiol 1987;9:785-801.
16. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-3175.
17. Luck H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 1965. p 885-894.
18. Stanley T, Omaye J, David T, Howarde ES. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Meth Enzymol 1979;62:3-11.
19. Hu M. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol 1994;233:380-382.
20. Ohkawa H, Oshishi N, Yagi K. Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RG. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Timmis AD. Lipid peroxidation associated with successful thrombolysis. Lancet 1990;335:741-743.
23. Hudson KF. A phenomenon of paradox: Myocardial reperfusion injury. Heart Lung 1994;23:384-393.
24. Hess ML, Kukreja RC. What are the prospects of antioxidants as a new therapeutic modality? Dialog Cardiovasc Med 1998;3:38-44.
25. Young IS, Purvis JA, Lightbody JH, Adgey AJ, Trimble ER. Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction. Eur Heart J 1993;14:1027-1033.
26. Maxwell SRJ, Lip Gyh. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997;58:95-117.
27. Horwitz LD, Kong Y, Robertson AD. Timing of treatment for myocardial reperfusion injury. J Cardiovasc Pharmacol 1999;33:19-29.
28. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-1828.
29. Gutteridge JMC, Halliwell B. Reoxygenation injury and antioxidant protection: A tale of two paradoxes. Arch Biochem Biophys 1990;283:223-226.
30. Gutteridge JMC. Iron promotes Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986b;201:291-295.
31. Guleria RS, Jain Amita, Tiwari V, Misra MK. Protective effect of green tea extract against the erythrocytic oxidative stress injury during Mycobacterium tuberculosis infection in mice. Mol Cell Biochem 2002;236:173-181.
32. Barton Duell P. Prevention of atherosclerosis with dietary antioxidants: Fact or Fiction? Symposium: Formation, metabolism and physiological effects of oxidatively modified low density lipo-protein. J Nutr 1996;126:1067S-1071S.
33. Santillo M, Mondola P, Milone A, et al. Ascorbate administration to normal and cholesterol fed rats inhibits in vitro TBARS formation in serum and liver homogenates. Life Sci 1996;58:1101-1108.
34. Aulinskas TH, Van Der Westhuyzen DR, Coetzee GA. Ascorbate increases the number of low density lipoprotein receptors in cultured smooth muscle cells. Atherosclerosis 1983;47:159-171.
35. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in Ischemia-reperfusion injury. Cardiovascular Res 2000;47:446-456.
36. Winkler BS. In vitro oxidation of ascorbic acid and its prevention by GSH. Biochim Biophys Acta 1987;925:258-264.
37. Basu S, Som S, Deb S, Mukerjee D, Chatterjee IB. Dehydroascorbic acid reduction in human erythrocytes. Biochem Biophys Res Commun 1979;90:1335-1340.
38. Wells WW, Xu DP, Yang YF, Rocque PA. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem 1990;265:15361-15364.
39. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview. Cardiovasc Drugs Ther 1991; 5(suppl):249-268.